[PRESS RELEASE] – DENVER, Jan. 30, 2025 – Willow Industries, an industry leader in cannabis decontamination technology and microbial control services, is excited to announce the launch of HALO, the first-of-its-kind cannabis terpene infusion machine. Engineered in partnership with Abstrax, a leader in cannabis research and terpene innovation, HALO was created to address the key challenges and safety concerns of current terpene infusion methods.
Driven by its mission to standardize quality and empower cultivators to provide clean, safe products, Willow Industries has developed HALO, a closed-loop system that revolutionizes the way cannabis flower is infused with terpenes. The machine employs a precise and controlled infusion process that aerosolizes liquid terpenes to optimize distribution, minimize waste, and maximize efficiency.
Featuring an enclosed drum loading system, minimal labor requirements, advanced tracking software and customizable settings, the HALO is a seamless solution for cultivators aiming to amplify their product offerings.
Key Features and Benefits:
- Efficiency: Optimizes the infusion process, reducing time and labor compared to manual application methods.
- Consistency: Delivers uniform terpene coverage, ensuring each batch meets high-quality standards.
- Controlled Environment: Reduces risks of cross-contamination through a clean, enclosed application system.
Specifications:
- Process Time: Completes infusion in approximately 30 minutes, including a cleaning cycle.
- Dimensions: 52" W x 48" L x 63" H
- Power: 110 VAC 50/60 Hz 15A.
"Our goal at Willow Industries has always been to raise the bar for quality and safety in the cannabis industry," Willow Industries founder and CEO Jill Ellsworth said. "We’re incredibly excited to partner with Abstrax to bring HALO to the market. By combining cutting-edge science with innovative engineering, HALO brings a revolutionary terpene infusion system that delivers precision, consistency, and safety. Together, we're setting a new standard for cannabis quality and innovation."
Willow's partnership with Abstrax has enabled the company to integrate advanced terpene infusion science and refine formulations while leveraging the latest data and practical applications for the HALO system. With this advanced infusion process, cultivators can confidently achieve consistent results with every batch.
"Through this collaboration, Abstrax and Willow are innovating to set a new standard," Abstrax CEO Kevin Koby said. "HALO represents a major step forward in how we approach terpene infusion. By harnessing Abstrax's expertise and the precision of the HALO system, operators can now create products with unmatched consistency and safety, all while elevating the cannabis experience. We're thrilled to be at the forefront of this industry."
